The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 11, 2021
Filed:
Aug. 11, 2020
Applicant:
Duquesne University of the Holy Spirit, Pittsburgh, PA (US);
Inventor:
Aleem Gangjee, Allison Park, PA (US);
Assignee:
Duquesne University of The Holy Spirit, Pittsburgh, PA (US);
Primary Examiner:
Int. Cl.
CPC ...
C07D 487/14 (2006.01); C07D 495/04 (2006.01); C07D 487/04 (2006.01); A61K 31/343 (2006.01); C07D 403/02 (2006.01); A61K 31/505 (2006.01); C07D 405/02 (2006.01); A61K 31/4709 (2006.01); C07D 239/48 (2006.01);
U.S. Cl.
CPC ...
C07D 495/04 (2013.01); A61K 31/343 (2013.01); A61K 31/4709 (2013.01); A61K 31/505 (2013.01); C07D 239/48 (2013.01); C07D 403/02 (2013.01); C07D 405/02 (2013.01); C07D 487/04 (2013.01);
Abstract
The present invention discloses a compound of the formula: wherein R is hydrogen or an alkyl group having from one to ten carbon atoms, or a compound of the formula wherein the S is replaced by CHor O, and optionally comprising a pharmaceutically acceptable salt or hydrate thereof. A method of treating a patient having cancer or a disease comprising administering to a patient an effective amount of the compound or pharmaceutically acceptable salt or hydrate thereof.